Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report


  • Products Id :- 96F0FC1F-BD61-4988-9D9B-89CFBC31B2C9
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments

Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.

Key Highlights

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Company Snapshot

Acorda Therapeutics, Inc.: Company Overview

Acorda Therapeutics, Inc.: Overview and Key Facts

Acorda Therapeutics, Inc.: Overview

Acorda Therapeutics, Inc.: Key Facts

Acorda Therapeutics, Inc.: Key Employees

Acorda Therapeutics, Inc.: Key Employee Biographies

Acorda Therapeutics, Inc.: Major Products and Services

Acorda Therapeutics, Inc.: Company History

Acorda Therapeutics, Inc.: Management Statement

Acorda Therapeutics, Inc.: Locations and Subsidiaries

Acorda Therapeutics, Inc.: Key Competitors

Acorda Therapeutics, Inc.: Company Analysis

Acorda Therapeutics, Inc.: Business Description

Acorda Therapeutics, Inc.: SWOT Analysis

Acorda Therapeutics, Inc.: SWOT Overview

Acorda Therapeutics, Inc.: Strengths

Acorda Therapeutics, Inc.: Weaknesses

Acorda Therapeutics, Inc.: Opportunities

Acorda Therapeutics, Inc.: Threats

Acorda Therapeutics, Inc.: Corporate Financial Deals Activity

Acorda Therapeutics, Inc.: Financial Deals Overview

Acorda Therapeutics, Inc.: Targets and Partners

Acorda Therapeutics, Inc.: Top Deals 2013-2017YTD*

Acorda Therapeutics, Inc.: Advisors

Acorda Therapeutics, Inc.: Top Legal Advisors

Acorda Therapeutics, Inc.: Top Financial Advisors

Acorda Therapeutics, Inc.: Mergers and Acquisitions

Acorda Therapeutics, Inc.: Recent Developments

Acorda Therapeutics, Inc.: News and Events Summary

Acorda Therapeutics, Inc.: Business Reorganization

Acorda Therapeutics, Inc.: Corporate Governance

Acorda Therapeutics, Inc.: Financial Performance

Acorda Therapeutics, Inc.: Grants

Acorda Therapeutics, Inc.: Red Flags/Distress Signals

Acorda Therapeutics, Inc.: Red Flags/DistressSignals

Acorda Therapeutics, Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Figure 2: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (US$m)

Figure 3: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Figure 4: Acorda Therapeutics, Inc.: M&A Activity by Geography (2013-YTD*2017)

Table 1: Acorda Therapeutics, Inc.: Key Facts

Table 2: Acorda Therapeutics, Inc.: Key Employees

Table 4: Acorda Therapeutics, Inc.: Key Competitors

Table 5: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Table 6: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (US$m)

Table 7: Acorda Therapeutics, Inc.: Targets and Partners

Table 8: Acorda Therapeutics, Inc.: Top Deals 2013-2017YTD*

Table 9: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)

Table 10: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)

Table 11: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Table 12: Acorda Therapeutics, Inc.: M&A Activity by Geography (2013-YTD*2017)

Table 13: Acorda Therapeutics, Inc.: News and Events Summary

Table 14: Acorda Therapeutics, Inc.: Business Reorganization

Table 15: Acorda Therapeutics, Inc.: Corporate Governance

Table 16: Acorda Therapeutics, Inc.: Financial Performance

Table 17: Acorda Therapeutics, Inc.: Grants

Table 18: Acorda Therapeutics, Inc.: Red Flags/Distress Signals

Table 19: Acorda Therapeutics, Inc.: Red Flags/DistressSignals

Table 20: Acorda Therapeutics, Inc.: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Acorda Therapeutics, Inc.

select a license

Single User License
USD 175 INR 11263
Site License
USD 350 INR 22526
Corporate User License
USD 525 INR 33789

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com